SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
June 29, 2022 08:30 ET | SciSparc Ltd
TEL AVIV, Israel, June 29, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty, clinical-stage pharmaceutical company focusing on the development of...
3BC Solvent-Free CBN and Delta-8 - Leading the Way to Better Cannabinoids
May 11, 2022 11:00 ET | 3BC, Inc
FARMINGTON, Conn., May 11, 2022 (GLOBE NEWSWIRE) -- 3BC is an industry leader and innovator in solvent-free cannabinoid distillation technology, helping manufacturers bring safe, clean, solvent-free...
Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor
February 03, 2022 09:00 ET | Nexien BioPharma, Inc.
DENVER, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Nexien BioPharma Inc. (OTCQB: NXEN) ("Nexien" or the "Company") today announced that it has retained Dr. Benedikt Schoser as an advisor to the Company. Dr....
Medium Juva Logo (002).png
Juva Life Advances JUVA-019 into Preclinical Development for Inflammatory Disease
January 06, 2022 04:00 ET | Juva Life Inc.
VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company...
grapefruit LOGO.png
Grapefruit USA, Inc. (OTCQB: GPFT) Leverages Its Patented Time Release Technology to Roll Out the World’s Most Effectively Bioavailable CBD Delivery Cream
December 06, 2021 06:00 ET | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere California-based...
Medium Juva Logo (002).png
Juva Life Launches Preclinical Comparative Study to Evaluate Anti-Inflammatory Properties of Candidate JUVA-019 in Conjunction With Other Well-Known Cannabinoids
November 30, 2021 04:00 ET | Juva Life Inc.
VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company...
logo 3.jpg
Red White & Bloom Florida Subsidiary Receives Cannabis Cultivation License at Apopka Greenhouse Site; Immediately Begins Grow Operations
October 12, 2021 07:00 ET | Red White & Bloom Brands Inc.
RWB launches Phase 1 of cultivation expansion in $1.3 Billion Florida market TORONTO and APOPKA, FL, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC:...
Vitality New.png
FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug
August 10, 2021 09:00 ET | Vitality Biopharma, Inc
CLEVELAND, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTC: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeutic...
Vantage Hemp Co. Launches Bulk Formulation Services
July 29, 2021 06:30 ET | Vantage Hemp
Greeley, Colorado., July 29, 2021 (GLOBE NEWSWIRE) -- Vantage Hemp Co. today launched bulk formulations of its sought-after pharmaceutical-grade CBD products, to meet increasing demand worldwide....
GRYN logo.jpg
Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development
July 27, 2021 08:30 ET | Green Hygienics Holdings Inc.
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces the appointment of David Racz as Senior...